Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Trust Cloud Computing ETF (SKYY) vs Smith & Nephew plc (SNN) Price & Performance

First Trust Cloud Computing ETFTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

First Trust Cloud Computing ETF vs Smith & Nephew plc — how do they compare? First Trust Cloud Computing ETF trades at $174.89 (market cap $3.47B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Smith & Nephew plc is far larger — about 3.2× First Trust Cloud Computing ETF's market cap, and Smith & Nephew plc pays a 2.95% dividend while First Trust Cloud Computing ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Trust Cloud Computing ETF for 85 Days and Smith & Nephew plc for 121 Days on average.

SKYYSNN
Market Cap
$3.47B$11.10B
Volume
176,1591,051,703
52-Week High
$174.89$37.17
52-Week Low
$104.16$26.42
Typical Hold Time
85 Days121 Days
Sector
—Health
Enterprise Value
—$14.13B
Dividend Yield
—2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Trust Cloud Computing ETF

SKYY (First Trust Cloud Computing ETF) trades at $170.14, down 0.37% on the day but near its 52-week high of $169.41. Technical indicators show a bullish trend with strong moving average support and neutral oscillators. The ETF benefits from strong secular trends in cloud computing and AI adoption, with recent news highlighting institutional position adjustments and positive sector momentum.

The outlook remains positive given cloud computing's growth trajectory and AI infrastructure demand. Key risks include sector concentration and market volatility. Analyst sentiment is generally favorable, though valuation metrics are not provided in current data. The ETF's diversified exposure to cloud infrastructure positions it well for continued technology adoption trends.

Smith & Nephew plc

Smith+Nephew (SNN) trades at $26.96, near its 52-week low, with bearish technical signals despite recent earnings beats. The company shows strong fundamentals with revenue growth to $6.16B in 2025 and improving profit margins of 10.08%. Recent product launches in trauma care and surgical robotics highlight innovation, but analyst sentiment remains cautious with 65% hold ratings.

Investment outlook is mixed: solid fundamentals and product pipeline offer upside, but technical weakness and analyst skepticism pose near-term risks. Key catalysts include execution on new product adoption and margin expansion, while risks involve competitive pressures and leadership transitions following the CFO's departure.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SKYY
100% Buy0% Sell
Avg holding period · 85 Days
SNN

No sentiment data available yet.

About First Trust Cloud Computing ETF

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.

Read more on SKYY →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →